Austin Walne is a Partner (recently promoted) at ARTIS Ventures. See sector focus and contact routes.
Austin Walne is a Partner (recently promoted) at ARTIS Ventures, a San Francisco-based venture capital firm founded in 2001, where he specializes in Frontier Tech and Applied AI at the intersection of technology and biology. His investment thesis focuses on early-to-mid-stage companies in the TechBio sector, targeting the convergence of computer science and life sciences including artificial intelligence, machine learning, diagnostics, and targeted therapeutics. ARTIS Ventures typically writes checks from early seed rounds through Series B, with a $200 million TechBio II fund driving these investments, though Walne’s specific lead versus follow behavior is not publicly detailed. Notable portfolio companies where Walne sits on the board include Locus Biosciences, SecondFront, and ExperienceEnklu. The firm’s distinctive point of view centers on applying engineering principles and data-enabled discovery to healthcare as an early leader in TechBio. No public writing or distinctive personal commentary by Walne himself is found in the available sources.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in San Francisco.
Investors like Austin Walne · Full investor directory · Investor access · Company funding database